Phage lysin stabilizes vaginal microbiome: Phagomed accelerates R&D program against bacterial vaginosis.
Vienna-based biotech company PhagoMed Biopharma GmbH has discovered a novel drug candidate for the treatment of Bacterial Vaginosis and the re-stabilization of the vaginal microbiome. A dedicated R&D team has been established to develop this […]
